These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 6274140

  • 1. Serum prolactin levels and immunohistochemical localization of prolactin in trophoblastic disease.
    Ranta T, Wahlström T, Rutanen EM, Stenman UH, Seppälä M.
    Acta Pathol Microbiol Scand A; 1981 May; 89(3):235-9. PubMed ID: 6274140
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
    Takayama M, Soma H, Isaka K, Okudera K, Ogawa T, Kikuchi K.
    Gynecol Obstet Invest; 1987 May; 23(3):151-6. PubMed ID: 3036671
    [Abstract] [Full Text] [Related]

  • 3. Circulating placental proteins (hCG, SP1 and PP5) in trophoblastic disease.
    Lee JN, Salem HT, Chard T, Huang SC, Ouyang PC.
    Br J Obstet Gynaecol; 1982 Jan; 89(1):69-72. PubMed ID: 6277363
    [Abstract] [Full Text] [Related]

  • 4. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C, Goto S, Furuhashi Y, Tomoda Y.
    J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
    [Abstract] [Full Text] [Related]

  • 5. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY.
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [Abstract] [Full Text] [Related]

  • 6. Serum relaxin in patients with invasive mole, choriocarcinoma and persistent trophoblastic disease.
    Seki K, Uesato T, Kato K.
    Endocrinol Jpn; 1986 Oct; 33(5):727-33. PubMed ID: 3030714
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY, Yen GL.
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [Abstract] [Full Text] [Related]

  • 9. Pregnancy-specific beta-1-glycoprotein in trophoblastic disease.
    Rutanen EM, Seppälä M.
    J Clin Endocrinol Metab; 1980 Jan; 50(1):57-61. PubMed ID: 6243133
    [No Abstract] [Full Text] [Related]

  • 10. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
    Jones WB, Lehr M, Lewis JL.
    Surg Forum; 1973 Jan; 24():563-5. PubMed ID: 4377042
    [No Abstract] [Full Text] [Related]

  • 11. Trophoblastic disease monitoring: Evaluation of pregnancy-specific beta 1-glycoprotein.
    O'Brien TJ, Engvall E, Schlaerth JB, Morrow CP.
    Am J Obstet Gynecol; 1980 Oct 01; 138(3):313-20. PubMed ID: 6251725
    [Abstract] [Full Text] [Related]

  • 12. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI, Kacinski BM, Stanley ER.
    Gynecol Oncol; 2001 Mar 01; 80(3):383-6. PubMed ID: 11263936
    [Abstract] [Full Text] [Related]

  • 13. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M, el-Shobokshy AS, el-Noury AI.
    Cytokine; 1995 Feb 01; 7(2):171-5. PubMed ID: 7540057
    [Abstract] [Full Text] [Related]

  • 14. Circulating concentrations of specific placental proteins (human chorionic gonadotropin, pregnancy-specific beta-1 glycoprotein, and placental protein 5) in untreated gestational trophoblastic tumors.
    Lee JN, Salem HT, Al-Ani AT, Chard T, Huang SC, Ouyang PC, Wei PY, Seppälä M.
    Am J Obstet Gynecol; 1981 Mar 15; 139(6):702-4. PubMed ID: 6971058
    [Abstract] [Full Text] [Related]

  • 15. Clinical and laboratory investigation of a virilized woman with placental-site trophoblastic tumor.
    Nagelberg SB, Rosen SW.
    Obstet Gynecol; 1985 Apr 15; 65(4):527-34. PubMed ID: 2984618
    [Abstract] [Full Text] [Related]

  • 16. Gestational trophoblastic diseases: the ratio of choriogonadotropin to specific pregnancy protein, hCG/SP1, provides useful diagnostic and prognostic evidence.
    Szymendera JJ, Ploch E, Zalucka K, Sikorowa L, Kaminska JA, Gadek A.
    Gynecol Oncol; 1986 Feb 15; 23(2):149-59. PubMed ID: 3002918
    [Abstract] [Full Text] [Related]

  • 17. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N.
    Gynecol Oncol; 1982 Jun 15; 13(3):393-8. PubMed ID: 6178652
    [No Abstract] [Full Text] [Related]

  • 18. Placental proteins (SP1, hCG, PP5) and alpha 2-PAG in trophoblastic diseases.
    Than GN, Bohn H, Csaba IF, Szabó DG, Karg NJ, Göcze P.
    Arch Gynecol; 1981 Jun 15; 231(1):33-9. PubMed ID: 6174083
    [Abstract] [Full Text] [Related]

  • 19. Comparison of human chorionic gonadotrophin concentrations in the sera of patients with normal and abnormal pregnancy measured by radio-immunoassay and immunoradiometric assay.
    Norman RJ, Buck RH, Joubert SM.
    S Afr Med J; 1989 Apr 01; 75(7):318-9. PubMed ID: 2538933
    [Abstract] [Full Text] [Related]

  • 20. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
    Grinevich IuA, Tatarinov IuS, Iugrinova LG, Olefirenko GA, Dotsenko IuS.
    Vopr Onkol; 1981 Apr 01; 27(12):19-23. PubMed ID: 6275607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.